CCL19 and cancer: Thus, attenuated CXCL12, CXCL13, and CCL19 levels in the TME may limit the interactions between malignant cells and surrounding non-neoplastic immune cells, thereby contributing to mobilization of lymphoid malignant cells from tumor tissues to the peripheral bloodstream through a cancer cell-independent mechanism.